Alembic Pharmaceuticals recalls Tobramycin Ophthalmic Solution 0.3% 5mL bottles due to failed impurities and degradation specifications. Rx only product with specific lot numbers and expiration dates.
“Alembic Tobramycin Ophthalmic Solution Recall: Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33233-alembic-tobramycin-ophthalmic-solution-recall-impurities-risk. Based on FDA recall #D-1086-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1086-2023%22&limit=1).
Alembic Pharmaceuticals voluntarily recalled Tobramycin Ophthalmic Solution USP, 0.3%, 5mL bottles due to failed impurities and degradation specifications, the FDA announced on July 27, 2023. The recall affects 82,400 bottles distributed nationwide.
How to tell if you have it
Brand: Alembic Pharmaceuticals
Product: Tobramycin Ophthalmic Solution USP, 0.3%, 5mL bottle, Rx only
NDC: 62332-518-05
Lot codes: AMR103 (Exp: 10/2023), AMR201 (Exp: 06/2024)
Manufacturer: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA
The hazard
The product failed impurities and degradation specifications. The FDA classified the recall as Class III.
Context
GovInfoNow's records show Alembic Pharmaceuticals has one other recall on record since June 22, 2023: a June 22, 2023 recall of Diclofenac Topical Solution for defective delivery system risk. Other recent recalls of similar products include an August 27, 2026 recall of Macleods Olanzapine Tablets 5mg for impurities that may cause harm, a November 26, 2025 recall of Sun Pharmaceutical Clindamycin Phosphate Topical Solution for impurity risk, and a December 16, 2025 recall of Alembic Fesoterodine Tablets for diester impurity risk.
How to tell if you have this one
Check for the product name 'Tobramycin Ophthalmic Solution USP 0.3% 5mL', manufactured by Alembic Pharmaceuticals in Bedminster, NJ. Look for lot numbers AMR103 (expiring 10/2023) or AMR201 (expiring 06/2024).
Brand
Alembic Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name, lot number, and expiration date to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1086-2023 (July 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1086-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.